Compare CYCU & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYCU | AIDX |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | United States |
| Employees | 74 | 14 |
| Industry | | Precision Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7M | 6.7M |
| IPO Year | N/A | N/A |
| Metric | CYCU | AIDX |
|---|---|---|
| Price | $0.82 | $0.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 31.6M | 101.3K |
| Earning Date | 06-05-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.92 | N/A |
| Revenue Next Year | $10.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.16 | $0.40 |
| 52 Week High | $7.13 | $14.09 |
| Indicator | CYCU | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 57.34 | 29.70 |
| Support Level | $0.78 | N/A |
| Resistance Level | $1.05 | $0.57 |
| Average True Range (ATR) | 0.24 | 0.03 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 41.32 | 17.62 |
Cycurion Inc. provides information technology security solutions through its subsidiaries. The company continually strives to deliver top-notch services in risk management, cybersecurity, information assurance, systems engineering, and help desk solutions. The company has one reportable segment, which is the delivery of products and services in the areas of information technology, electronic warfare, information warfare and cybersecurity in the governmental and commercial markets. The company generates the majority of its revenue from Advisory Consulting services, with small portion revenue generated from Managed Security Service Practice (MSSP) and Software as a Service (Saas).
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.